Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Micro Interventional Devices, Oscor team up in structural heart disease

Executive Summary

Oscor Inc. granted Micro Interventional Devices Inc. (MID) non-exclusive global rights to its patented catheter technology, while Oscor gets exclusive manufacturing rights to MID's MIA (Minimally Invasive Annuloplasty) devices.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • Product or Technology Swap
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register